4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-19-031184
SVP & Chief Scientific Officer sold 3,461 shares at $31.37 ($108,572)
From the SEC's structured data for this filing
Trades in this filing
Doberstein Stephen K · SVP & Chief Scientific Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-05-16 | Sale : show line 1 in the form | −3,461 | $31.37 | $108,572 | 95,913 | D |
| Open-market sales · 3,461 sh · avg $31.37 · $108,572 | ||||||
Loading xslF345X03/doc4.xml…